๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Darbepoetin alfa - Medicines in Ireland

25 authorised products containing Darbepoetin alfa, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 25 authorised medicines
MedicineActive substanceLicence holderStatus
Aranesp 10 micrograms solution for injection in pre-filled pen
EU/1/01/185/045, 057
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 10 micrograms solution for injection pre-filled syringe
EU/1/01/185/001-002
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 100 micrograms solution for injection in pre-filled pen
EU/1/01/185/053, 065
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 100 micrograms solution for injection pre-filled syringe
EU/1/01/185/017-018
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 130 micrograms solution for injection in pre-filled pen
EU/1/01/185/072, 073
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 15 micrograms solution for injection in pre-filled pen.
EU/1/01/185/046, 058
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 15 micrograms solution for injection pre-filled syringe
EU/1/01/185/003-004
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 150 micrograms solution for injection in pre-filled pen
EU/1/01/185/054, 066
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 150 micrograms solution for injection pre-filled syringe
EU/1/01/185/019-020
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 20 micrograms solution for injection in pre-filled pen
EU/1/01/185/047, 059
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 20 micrograms solution for injection pre-filled syringe
EU/1/01/185/005-006
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 30 micrograms solution for injection in pre-filled pen
EU/1/01/185/048, 060
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 30 micrograms solution for injection pre-filled syringe
EU/1/01/185/007-008
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 300 micrograms solution for injection in pre-filled pen
EU/1/01/185/055, 067
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 300 micrograms solution for injection pre-filled syringe
EU/1/01/185/021-022
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 40 micrograms solution for injection in pre-filled pen
EU/1/01/185/049, 061
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 40 micrograms solution for injection pre-filled syringe
EU/1/01/185/009-010
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 50 micrograms solution for injection in pre-filled pen
EU/1/01/185/050, 062
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 50 micrograms solution for injection pre-filled syringe
EU/1/01/185/011-012
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 500 micrograms solution for injection in pre-filled pen
EU/1/01/185/056, 068
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 500 micrograms solution for injection pre-filled syringe
EU/1/01/185/031-032
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 60 micrograms solution for injection in pre-filled pen
EU/1/01/185/051, 063
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 60 micrograms solution for injection pre-filled syringe
EU/1/01/185/013-014
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 80 micrograms solution for injection in pre-filled pen
EU/1/01/185/052, 064
Darbepoetin alfa Amgen Europe B.V., โ€”
Aranesp 80 micrograms solution for injection pre-filled syringe
EU/1/01/185/015-016
Darbepoetin alfa Amgen Europe B.V., โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 14 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.